News & Analysis on Clinical Trial Services & Contract Research And Development
Cyclacel has received a US patent that covers a novel series of pyrimidine small molecules shown to inhibit the progress of cells through the cancer cell cycle. The patented compounds may be useful as therapeutics for cancer, inflammatory and...
Nanotechnology for molecular targeting and drug delivery is set to become a trillion-dollar industry, fuelled by the pharmaceutical industry, which faces increasingly challenging market conditions. This has lead to an intensified search for better...
ITI Life Sciences and CXR Biosciences together with Artemis Pharmaceuticals have entered into a £5.5 million (€7.9 million) R&D programme to develop new screening and safety models to more accurately predict the effects of drug compounds and their...
Researchers have found a protein, which plays a significant role in colorectal carcinoma. The protein blocks the ability of tumours to activate a natural self-destruct mechanism that would clear the cancer from the body.
New statistics released today show that total US investments in R&D made by the biotechnology and pharmaceutical industry topped $38.8 billion (€29.3 billion) during 2004. This beats the $34.5 billion total set in 2003 and demonstrates the steady...